|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 04798662.5 (espacenet) (Federated) (European Patent Register), 20041124 | | Patent/reg. no. and date | DK/EP 1708679, 20081112 | | Publication date | 20061011 | | Priority no. and date | SE 0303179, 20031126 | | EP pub. no. and date |
EP 1708679 20061011 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | AST 101287-1X | | Inventor | ROGUEDA, Philippe, AstraZeneca R & D Charnwood
Bakewell Road
Loughborough,
Leicestershire LE11 5RH, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/167 (2006.01) , A61K 31/573 (2006.01) , A61K 9/00 (2006.01) | | Title | Farmaceutiske sprayformulering, der omfatter en hydrofluoralkan og en acyleret cyclodextrin | | Int. application no. | GB2004004957 | | Int. publication no. | WO2005053637 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
